Search by Drug Name or NDC

    NDC 51655-0412-60 Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1 Details

    Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1

    Lisinopril and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals, LLC. The primary component is HYDROCHLOROTHIAZIDE; LISINOPRIL.

    Product Information

    NDC 51655-0412
    Product ID 51655-412_f3055919-aff5-72e7-e053-2995a90ace4d
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lisinopril and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lisinopril and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 10
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
    Labeler Name Northwind Pharmaceuticals, LLC
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077912
    Listing Certified Through 2024-12-31

    Package

    NDC 51655-0412-60 (51655041260)

    NDC Package Code 51655-412-60
    Billing NDC 51655041260
    Package 100 TABLET in 1 BOTTLE, PLASTIC (51655-412-60)
    Marketing Start Date 2020-09-30
    NDC Exclude Flag N
    Pricing Information N/A